Gene

Genetics News Science

A recently found gene could influence lifespan

By Journal Updates
7 September 2024

gene research

Researchers found that among all proteins, one protein-OSER1, greatly influences longevity.

Discover More

AstraZeneca’s Enhertu EU Approval: Enhertu Plus Pertuzumab Cleared as First-Line Therapy for HER2-Positive Metastatic Breast Cancer

Regulatory Approval Healthcare & Pharmaceuticals News Oncology

AstraZeneca’s Enhertu EU Approval: Enhertu Plus Pertuzumab Cleared as First-Line Therapy for HER2-Positive Metastatic Breast Cancer

1 September 20262 September 2026

Regulatory Intelligence Desk

Lilly Merida Biosciences Acquisition: Eli Lilly to Pay $2.875 Billion for Precision Autoantibody Therapies

Merger & Acquisitions Business Healthcare & Pharmaceuticals News

Lilly Merida Biosciences Acquisition: Eli Lilly to Pay $2.875 Billion for Precision Autoantibody Therapies

31 August 20261 September 2026

BiotechReality Business Intelligence Desk

Roche Vabysmo PCV Study Shows Sustained Two-Year Results in Difficult-to-Treat nAMD Subtype

Clinical Data Healthcare & Pharmaceuticals News

Roche Vabysmo PCV Study Shows Sustained Two-Year Results in Difficult-to-Treat nAMD Subtype

28 August 202628 August 2026

Clinical Trials & Data Desk

TEZSPIRE Eosinophilic Esophagitis Trial: Amgen, AstraZeneca Report Positive Phase 3 CROSSING Results

Clinical Data Healthcare & Pharmaceuticals News

TEZSPIRE Eosinophilic Esophagitis Trial: Amgen, AstraZeneca Report Positive Phase 3 CROSSING Results

27 August 202628 August 2026

Clinical Trials & Data Desk

Abbott Libre Duo 10 Day Wins FDA Authorization as World’s First Dual Glucose-Ketone Sensor

Technology Diabetes Healthcare & Pharmaceuticals News

Abbott Libre Duo 10 Day Wins FDA Authorization as World’s First Dual Glucose-Ketone Sensor

26 August 202626 August 2026

Regulatory Intelligence Desk

Johnson & Johnson’s IMAAVY Nipocalimab-aahu Wins FDA Approval as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia

Healthcare & Pharmaceuticals Autoimmune Diseases News Regulatory Approval

Johnson & Johnson’s IMAAVY Nipocalimab-aahu Wins FDA Approval as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia

25 August 202625 August 2026

Regulatory Intelligence Desk